数学模型用于预测艾滋病感染

The first few hours to days following exposure to human immunodeficiency virus (HIV) can be of critical importance in determining if infection occurs in a patient. But the low numbers of viruses and infected cells at this stage makes it very difficult to study these events in humans or animal models. Theoretical mathematical models can help analyze¹ viral dynamics² in this early phase, and hence offer insights into therapeutic³ and prevention strategies, as evidenced by a paper published last month in the SIAM Journal on Applied⁴ Mathematics.   In a paper titled Stochastic Analysis of Pre- and Postexposure Prophylaxis against HIV Infection, authors Jessica Conway, Bernhard Konrad, and Daniel Coombs present theoretical models of HIV dynamics immediately following exposure to the virus, thus providing a method to study infection and treatment at these early stages, as well as come up with preemptive（先发制人的） strategies for prevention.   Different classes of HIV drugs target different phases of the viral life cycle. For instance, drugs may prevent the viral genetic⁵ material from being integrated into the host cell or disrupt the formation of new viral particles. "In models of chronic⁶ infection, the different drug mechanisms⁷ end up having similar effects in mathematical models," explains author Daniel Coombs. "But during early infection, every step of the life cycle is critical for the small virus population to persist in the host, and this leads to interesting differences between the efficacies of different drugs in this phase."   The authors create stochastic models to analyze viral dynamics and to understand how protective or preventative drug treatment prior to or immediately following exposure can act to reduce risk of infection under various scenarios⁸.   "There's a lot of discussion in public health circles about the potential of pre- and post-exposure prophylaxis (PrEP and PEP respectively) against HIV," says Coombs. "Clinical practices for PEP are based on empirical findings with older, less effective drugs, while PrEP is very new and still under development." For this reason, clinical trials of PrEP and PEP often show variable success, making it hard to predict their effectiveness.   "We used stochastic models to investigate different choices of treatment strategies for both PEP and PrEP. Our results are in good agreement with clinical findings, and also show possible directions for future investigation," says Coombs.   The paper proposes a simple and a more complex model. The simple one-compartment model of HIV infection uses a mathematical formula that incorporates the dynamics between replication-competent and -incompetent viruses, as well as infected cells in the eclipse phase (when they do not produce virus) and in the productive phase (when they do). The formula also includes the rate of infection of new cells, the rate of viral clearance#p#分页标题#e#⁹ (due to removal or inactivation), as well as the interaction of different types of drugs. The complex (two-compartment) model is similar, but additionally incorporates different cell types and transport dynamics -- two factors that are also important in the initiation¹⁰ of HIV infection.